JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tillson, E. K.
Right arrow Articles by Beyer, K. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tillson, E. K.
Right arrow Articles by Beyer, K. H.
Journal of Pharmacology And Experimental Therapeutics, Vol. 111, Issue 4, 385-394, 1954
Copyright © 1954 by American Society for Pharmacology and Experimental Therapeutics


THE DETERMINATION OF PROBENECID (BENEMID) IN BODY FLUIDS

Elizabeth K. Tillson 1, Grace S. Schuchardt 1, Jacqueline K. Fishman 1, and Karl H. Beyer 1

1 Pharmacology Section, Sharp & Dohme Division, Merck & Co., Inc., West Point, Pa.

Two analytical methods for the determination of Benemid in body fluids have been described. The spectrophotometric procedure, recommended for carefully controlled experimental work, depends upon the fact that the compound can be extracted into chloroform from an acidic, aqueous medium and in turn reextracted into 0.1 N NaOH. The alkaline solution is examined spectrophotometrically at a wave length of 242.5 mµ.

In the second method the drug is also extracted into chloroform from an acidic, aqueous medium. The chloroform layer is shaken with an aqueous solution of methylene blue. The colored salt formed at the interface is soluble in the solvent, making it possible to determine the amount present by examining the chloroform layer colorimetrically. This procedure is the method of choice for clinical studies, since it is unaffected by most medicaments and endogenous metabolic products.

The experiments presented herein indicate that Benemid is well absorbed following oral administration, that a considerable amount is adsorbed on plasma protein (albumin), and that the adsorption curve corresponds to a physical adsorption isotherm. Evidence has also been given for the appearance of one and probably two hydrolyzable metabolites in the urine of dogs that have received repeated large doses of Benemid.

Submitted on March 1, 1954







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1954 by the American Society for Pharmacology and Experimental Therapeutics.